155 related articles for article (PubMed ID: 37658293)
41. Association between patient-reported HIV status and provider recommendation for screening in an opportunistic cervical Cancer screening setting in Jos, Nigeria.
Musa J; Achenbach CJ; Evans CT; Jordan N; Daru PH; Hou L; Murphy RL; Adewole IF; Simon MA
BMC Health Serv Res; 2018 Nov; 18(1):885. PubMed ID: 30466437
[TBL] [Abstract][Full Text] [Related]
42. Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control.
Hall MT; Smith MA; Simms KT; Barnabas R; Murray JM; Canfell K
Int J Cancer; 2021 Jul; 149(2):297-306. PubMed ID: 33634857
[TBL] [Abstract][Full Text] [Related]
43. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
[TBL] [Abstract][Full Text] [Related]
44. Scaling up cervical cancer prevention in Western Kenya: Treatment access following a community-based HPV testing approach.
Mungo C; Ibrahim S; Bukusi EA; Truong HM; Cohen CR; Huchko M
Int J Gynaecol Obstet; 2021 Jan; 152(1):60-67. PubMed ID: 32347550
[TBL] [Abstract][Full Text] [Related]
45. Performance of HPV Genotyping Combined with p16/Ki-67 in Detection of Cervical Precancer and Cancer Among HPV-Positive Chinese Women.
Jiang MY; Wu Z; Li T; Yu L; Zhang SK; Zhang X; Qu P; Sun P; Xi MR; Liu X; Liao G; Sun L; Zhang Y; Chen W; Qiao YL
Cancer Prev Res (Phila); 2020 Feb; 13(2):163-172. PubMed ID: 31871224
[TBL] [Abstract][Full Text] [Related]
46. National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study.
Smith MA; Sherrah M; Sultana F; Castle PE; Arbyn M; Gertig D; Caruana M; Wrede CD; Saville M; Canfell K
BMJ; 2022 Mar; 376():e068582. PubMed ID: 35354610
[TBL] [Abstract][Full Text] [Related]
47. Cervical cancer screening through human papillomavirus testing in community health campaigns versus health facilities in rural western Kenya.
Huchko MJ; Ibrahim S; Blat C; Cohen CR; Smith JS; Hiatt RA; Bukusi E
Int J Gynaecol Obstet; 2018 Apr; 141(1):63-69. PubMed ID: 29197067
[TBL] [Abstract][Full Text] [Related]
48. Implementing the 3T-approach for cervical cancer screening in Cameroon: Preliminary results on program performance.
Levy J; de Preux M; Kenfack B; Sormani J; Catarino R; Tincho EF; Frund C; Fouogue JT; Vassilakos P; Petignat P
Cancer Med; 2020 Oct; 9(19):7293-7300. PubMed ID: 32757469
[TBL] [Abstract][Full Text] [Related]
49. Cervical cancer screening and treatment, HIV infection, and age: Program implementation in seven regions of Namibia.
Korn AK; Muzingwani L; O'Bryan G; Ensminger A; Boylan AD; Kafidi EL; Kashali M; Ashipala L; Nitschke AM; Dziuban EJ; Forster N; Eckert LO; O'Malley G
PLoS One; 2022; 17(2):e0263920. PubMed ID: 35171941
[TBL] [Abstract][Full Text] [Related]
50. Cervical cancer screening by high risk HPV testing in routine practice: results at one year recall of high risk HPV-positive and cytology-negative women.
Del Mistro A; Frayle H; Ferro A; Callegaro S; Del Sole A; Stomeo A; Cirillo E; Fedato C; Pagni S; Barzon L; Zorzi M;
J Med Screen; 2014 Mar; 21(1):30-7. PubMed ID: 24488593
[TBL] [Abstract][Full Text] [Related]
51. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
52. Cervical cancer screening program based on primary DNA-HPV testing in a Brazilian city: a cost-effectiveness study protocol.
Teixeira JC; Vale DB; Bragança JF; Campos CS; Discacciati MG; Zeferino LC
BMC Public Health; 2020 Apr; 20(1):576. PubMed ID: 32345284
[TBL] [Abstract][Full Text] [Related]
53. Appraisal of willingness to vaccinate daughters with human papilloma virus vaccine and cervical cancer screening uptake among mothers of adolescent students in Abakaliki, Nigeria.
Azuogu BN; Umeokonkwo CD; Azuogu VC; Onwe OE; Okedo-Alex IN; Egbuji CC
Niger J Clin Pract; 2019 Sep; 22(9):1286-1291. PubMed ID: 31489868
[TBL] [Abstract][Full Text] [Related]
54. Management of HPV-positive women in cervical screening using results from two consecutive screening rounds.
Polman NJ; Veldhuijzen NJ; Heideman DAM; Snijders PJF; Meijer CJLM; Berkhof J
Int J Cancer; 2019 May; 144(9):2339-2346. PubMed ID: 30565673
[TBL] [Abstract][Full Text] [Related]
55. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
[TBL] [Abstract][Full Text] [Related]
56. Tanzanian women´s knowledge about Cervical Cancer and HPV and their prevalence of positive VIA cervical screening results. Data from a Prevention and Awareness Campaign in Northern Tanzania, 2017 - 2019.
Henke A; Kluge U; Borde T; Mchome B; Serventi F; Henke O
Glob Health Action; 2021 Jan; 14(1):1852780. PubMed ID: 33371824
[No Abstract] [Full Text] [Related]
57. Prevention of Cervical Cancer in Low-Resource African Settings.
Mulongo M; Chibwesha CJ
Obstet Gynecol Clin North Am; 2022 Dec; 49(4):771-781. PubMed ID: 36328679
[TBL] [Abstract][Full Text] [Related]
58. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.
Clarke MA; Cheung LC; Castle PE; Schiffman M; Tokugawa D; Poitras N; Lorey T; Kinney W; Wentzensen N
JAMA Oncol; 2019 Feb; 5(2):181-186. PubMed ID: 30325982
[TBL] [Abstract][Full Text] [Related]
59. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
60. Introduction of HPV testing for cervical cancer screening in Central America: The Scale-Up project.
Holme F; Jeronimo J; Maldonado F; Camel C; Sandoval M; Martinez-Granera B; Montenegro M; Figueroa J; Slavkovsky R; Thomson KA; de Sanjose S;
Prev Med; 2020 Jun; 135():106076. PubMed ID: 32247010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]